论文部分内容阅读
摘要目的探讨双能谱CT(DESCT)在静脉期区分良恶性椎体肿瘤的价值。方法本研究经机构伦理委员会批准,获得所有病人书面知情同意书。37例病人在静脉期行DESCT
Abstract Objective To investigate the value of dual-energy spectrum computed tomography (DESCT) in differentiating benign and malignant vertebral tumors in venous phase. Methods This study was approved by the Institutional Ethics Committee and obtained written informed consent from all patients. Thirty-seven patients underwent DESCT in the venous phase